Correlation Between Alx Oncology and Corvus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Alx Oncology and Corvus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alx Oncology and Corvus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alx Oncology Holdings and Corvus Pharmaceuticals, you can compare the effects of market volatilities on Alx Oncology and Corvus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alx Oncology with a short position of Corvus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alx Oncology and Corvus Pharmaceuticals.

Diversification Opportunities for Alx Oncology and Corvus Pharmaceuticals

-0.85

Correlation Coefficient

Alx Oncology  Corvus Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Alx and Corvus is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Alx Oncology Holdings and Corvus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corvus Pharmaceuticals and Alx Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alx Oncology Holdings are associated (or correlated) with Corvus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corvus Pharmaceuticals has no effect on the direction of Alx Oncology i.e., Alx Oncology and Corvus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Alx Oncology and Corvus Pharmaceuticals

Given the investment horizon of 90 days Alx Oncology Holdings is expected to under-perform the Corvus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Alx Oncology Holdings is 1.07 times less risky than Corvus Pharmaceuticals. The stock trades about -0.11 of its potential returns per unit of risk. The Corvus Pharmaceuticals is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest  404.00  in Corvus Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  505.00  from holding Corvus Pharmaceuticals or generate 125.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Alx Oncology Holdings  vs.  Corvus Pharmaceuticals

Alx Oncology Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Alx Oncology Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Corvus Pharmaceuticals

Risk-Adjusted Performance

22 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Corvus Pharmaceuticals are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Corvus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Alx Oncology and Corvus Pharmaceuticals

The main advantage of trading using opposite Alx Oncology and Corvus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alx Oncology position performs unexpectedly, Corvus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corvus Pharmaceuticals will offset losses from the drop in Corvus Pharmaceuticals' long position.

The idea behind Alx Oncology Holdings and Corvus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.